Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Trial Profile

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Onapristone (Primary) ; Onapristone (Primary)
  • Indications Advanced breast cancer; Endometrial cancer; Ovarian cancer; Solid tumours; Uterine cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Arno Therapeutics
  • Most Recent Events

    • 07 Jun 2016 Results from this trial and other trial (NCT02049190) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 02 Jun 2015 Results of immunohistochemical biomarker analysis and clinical benefit in phase I cohorts presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 02 Jun 2015 Results of phase I presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top